Xenon Ophthalmics Inc — Form D
Xenon Ophthalmics Inc of BELLEVILLE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-22. $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-08-22
- Form: D
- Accession: 0001988832-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $2.4M
- Minimum investment: $20K
- Investors: 16
- Date of first sale: 2019-08-15
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-490391
Issuer
- Name: Xenon Ophthalmics Inc
- CIK: 0001988832
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 55 SALTER PLACE, BELLEVILLE, NJ, 07109
- Phone: 9736194071
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Zeshan Kahn | Director | Belleville, NJ |
| Zeshan Kahn | Executive Officer | Belleville, NJ |
| Robert Gilligan | Director | Belleville, NJ |
| Zeshan Khan | Director | Belleville, NJ |
| Zeshan Khan | Executive Officer | Belleville, NJ |
| Steve Susanibar | Director | Belleville, NJ |
| Steve Susanibar | Executive Officer | Belleville, NJ |
| Bruce Stark | Director | Belleville, NJ |
| Michelle DeFossett | Director | Belleville, NJ |
Other filings by this issuer (1)
More